CDC’s Slippery Fiscal Slope

Proposed budget cuts could undermine the agency’s disease prevention efforts.

Written byMegan Scudellari
| 1 min read

Register for free to listen to this article
Listen with Speechify
0:00
1:00
Share

CDC Headquarters in Atlanta, GeorgiaBRETT WEINSTEIN, WIKIMEDIA COMMONS

Under President Obama's 2013 budget proposal, the Centers for Disease Control and Prevention's budget will be cut by $664 million, or 11 percent—the largest proposed cut of all the government’s health agencies, the Wall Street Journal reported. The administration has proposed to compensate for those cuts through two other sources of income that the CDC has tapped into in the past, but those sources are far from a sure thing.

One proposed source is payments from other public-health agencies, but that funding depends on Congressional approval, which can’t be guaranteed, Nature reported. Another source is the Prevention and Public Health Fund, which was established as part of the 2010 health care law. The fund, which was originally designed to support new disease-prevention programs, has already ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Meet the Author

Share
Illustration of a developing fetus surrounded by a clear fluid with a subtle yellow tinge, representing amniotic fluid.
January 2026

What Is the Amniotic Fluid Composed of?

The liquid world of fetal development provides a rich source of nutrition and protection tailored to meet the needs of the growing fetus.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies

Parse Logo

Parse Biosciences and Graph Therapeutics Partner to Build Large Functional Immune Perturbation Atlas

Sino Biological Logo

Sino Biological's Launch of SwiftFluo® TR-FRET Kits Pioneers a New Era in High-Throughout Kinase Inhibitor Screening

SPT Labtech Logo

SPT Labtech enables automated Twist Bioscience NGS library preparation workflows on SPT's firefly platform